Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Encompass Health Corporation stock logo
EHC
Encompass Health
$106.64
+0.0%
$102.94
$92.77
$127.99
$10.58B0.721.02 million shs708,777 shs
Hims & Hers Health, Inc. stock logo
HIMS
Hims & Hers Health
$25.06
+0.1%
$23.79
$13.74
$70.43
$5.71B2.4330.79 million shs20.61 million shs
Medpace Holdings, Inc. stock logo
MEDP
Medpace
$415.27
$463.68
$287.17
$628.92
$11.86B1.19489,282 shs286,753 shs
ResMed Inc. stock logo
RMD
ResMed
$202.03
+0.1%
$223.93
$198.61
$293.81
$29.43B0.841.43 million shs1.41 million shs
Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Encompass Health Corporation stock logo
EHC
Encompass Health
0.00%+0.41%+0.16%-3.07%-11.82%
Hims & Hers Health, Inc. stock logo
HIMS
Hims & Hers Health
0.00%-11.94%-12.78%+53.64%-61.11%
Medpace Holdings, Inc. stock logo
MEDP
Medpace
0.00%-2.06%-20.23%-2.98%+35.86%
ResMed Inc. stock logo
RMD
ResMed
0.00%-2.23%-11.35%-19.98%-19.75%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Encompass Health Corporation stock logo
EHC
Encompass Health
$106.64
+0.0%
$102.94
$92.77
$127.99
$10.58B0.721.02 million shs708,777 shs
Hims & Hers Health, Inc. stock logo
HIMS
Hims & Hers Health
$25.06
+0.1%
$23.79
$13.74
$70.43
$5.71B2.4330.79 million shs20.61 million shs
Medpace Holdings, Inc. stock logo
MEDP
Medpace
$415.27
$463.68
$287.17
$628.92
$11.86B1.19489,282 shs286,753 shs
ResMed Inc. stock logo
RMD
ResMed
$202.03
+0.1%
$223.93
$198.61
$293.81
$29.43B0.841.43 million shs1.41 million shs
Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Encompass Health Corporation stock logo
EHC
Encompass Health
0.00%+0.41%+0.16%-3.07%-11.82%
Hims & Hers Health, Inc. stock logo
HIMS
Hims & Hers Health
0.00%-11.94%-12.78%+53.64%-61.11%
Medpace Holdings, Inc. stock logo
MEDP
Medpace
0.00%-2.06%-20.23%-2.98%+35.86%
ResMed Inc. stock logo
RMD
ResMed
0.00%-2.23%-11.35%-19.98%-19.75%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Encompass Health Corporation stock logo
EHC
Encompass Health
3.11
Buy$144.1735.19% Upside
Hims & Hers Health, Inc. stock logo
HIMS
Hims & Hers Health
2.12
Hold$29.5017.70% Upside
Medpace Holdings, Inc. stock logo
MEDP
Medpace
2.20
Hold$467.0812.48% Upside
ResMed Inc. stock logo
RMD
ResMed
2.73
Moderate Buy$286.1841.65% Upside

Current Analyst Ratings Breakdown

Latest RMD, MEDP, EHC, and HIMS Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
5/13/2026
Hims & Hers Health, Inc. stock logo
HIMS
Hims & Hers Health
Lower Price TargetNeutral$32.00 ➝ $30.00
5/12/2026
Hims & Hers Health, Inc. stock logo
HIMS
Hims & Hers Health
DowngradeHold (C)Sell (D)
5/12/2026
Hims & Hers Health, Inc. stock logo
HIMS
Hims & Hers Health
Set Price Target$24.50
5/12/2026
Hims & Hers Health, Inc. stock logo
HIMS
Hims & Hers Health
Set Price Target$35.00
5/12/2026
Hims & Hers Health, Inc. stock logo
HIMS
Hims & Hers Health
Set Price Target$32.00
5/12/2026
Hims & Hers Health, Inc. stock logo
HIMS
Hims & Hers Health
Boost Price TargetNeutral$24.00 ➝ $28.00
5/12/2026
Hims & Hers Health, Inc. stock logo
HIMS
Hims & Hers Health
Lower Price TargetOverweight$35.00 ➝ $33.00
5/12/2026
Hims & Hers Health, Inc. stock logo
HIMS
Hims & Hers Health
Boost Price TargetBuy$30.00 ➝ $35.00
5/12/2026
Hims & Hers Health, Inc. stock logo
HIMS
Hims & Hers Health
Reiterated RatingNeutral
5/5/2026
Hims & Hers Health, Inc. stock logo
HIMS
Hims & Hers Health
Reiterated RatingHold$25.00
5/5/2026
Encompass Health Corporation stock logo
EHC
Encompass Health
Lower Price TargetOverweight$153.00 ➝ $140.00
(Data available from 5/18/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Encompass Health Corporation stock logo
EHC
Encompass Health
$5.94B1.78$8.89 per share11.99$31.98 per share3.33
Hims & Hers Health, Inc. stock logo
HIMS
Hims & Hers Health
$2.37B2.41$0.84 per share29.93$2.38 per share10.53
Medpace Holdings, Inc. stock logo
MEDP
Medpace
$2.53B4.69$17.01 per share24.41$16.30 per share25.48
ResMed Inc. stock logo
RMD
ResMed
$5.15B5.72$11.21 per share18.02$40.70 per share4.96
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Encompass Health Corporation stock logo
EHC
Encompass Health
$566.20M$5.9917.8016.512.3310.04%18.28%8.27%8/3/2026 (Estimated)
Hims & Hers Health, Inc. stock logo
HIMS
Hims & Hers Health
$128.37M-$0.09N/A51.1544.19-0.56%6.10%1.52%N/A
Medpace Holdings, Inc. stock logo
MEDP
Medpace
$451.12M$15.9126.1022.402.1117.19%120.89%24.79%7/20/2026 (Estimated)
ResMed Inc. stock logo
RMD
ResMed
$1.40B$10.3719.4816.681.2927.44%25.35%18.69%7/30/2026 (Estimated)

Latest RMD, MEDP, EHC, and HIMS Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/11/2026Q1 2026
Hims & Hers Health, Inc. stock logo
HIMS
Hims & Hers Health
$0.04-$0.40-$0.44-$0.40$616.84 million$608.10 million
4/30/2026Q1 2026
Encompass Health Corporation stock logo
EHC
Encompass Health
$1.51$1.60+$0.09$1.93$1.57 billion$1.59 billion
4/30/2026Q3 2026
ResMed Inc. stock logo
RMD
ResMed
$2.79$2.86+$0.07$2.74$1.42 billion$1.43 billion
4/22/2026Q1 2026
Medpace Holdings, Inc. stock logo
MEDP
Medpace
$3.74$4.28+$0.54$4.28$697.82 million$706.60 million
2/23/2026Q4 2025
Hims & Hers Health, Inc. stock logo
HIMS
Hims & Hers Health
$0.02$0.08+$0.06$0.08$619.48 million$617.82 million
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Encompass Health Corporation stock logo
EHC
Encompass Health
$0.760.71%-8.97%12.69%2 Years
Hims & Hers Health, Inc. stock logo
HIMS
Hims & Hers Health
N/AN/AN/AN/AN/A
Medpace Holdings, Inc. stock logo
MEDP
Medpace
N/AN/AN/AN/AN/A
ResMed Inc. stock logo
RMD
ResMed
$2.401.19%+6.33%23.14%13 Years

Latest RMD, MEDP, EHC, and HIMS Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
5/7/2026
Encompass Health Corporation stock logo
EHC
Encompass Health
quarterly$0.190.71%7/1/20267/1/20267/15/2026
4/30/2026
ResMed Inc. stock logo
RMD
ResMed
quarterly$0.601.18%5/14/20265/14/20266/18/2026
2/19/2026
Encompass Health Corporation stock logo
EHC
Encompass Health
quarterly$0.190.78%4/1/20264/1/20264/15/2026
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Encompass Health Corporation stock logo
EHC
Encompass Health
0.76
1.17
1.17
Hims & Hers Health, Inc. stock logo
HIMS
Hims & Hers Health
2.18
1.69
1.56
Medpace Holdings, Inc. stock logo
MEDP
Medpace
N/A
0.85
0.85
ResMed Inc. stock logo
RMD
ResMed
0.06
3.01
2.33

Institutional Ownership

CompanyInstitutional Ownership
Encompass Health Corporation stock logo
EHC
Encompass Health
97.25%
Hims & Hers Health, Inc. stock logo
HIMS
Hims & Hers Health
63.52%
Medpace Holdings, Inc. stock logo
MEDP
Medpace
77.98%
ResMed Inc. stock logo
RMD
ResMed
54.98%

Insider Ownership

CompanyInsider Ownership
Encompass Health Corporation stock logo
EHC
Encompass Health
1.80%
Hims & Hers Health, Inc. stock logo
HIMS
Hims & Hers Health
11.76%
Medpace Holdings, Inc. stock logo
MEDP
Medpace
20.50%
ResMed Inc. stock logo
RMD
ResMed
0.65%
CompanyEmployeesShares OutstandingFree FloatOptionable
Encompass Health Corporation stock logo
EHC
Encompass Health
42,00099.20 million97.41 millionOptionable
Hims & Hers Health, Inc. stock logo
HIMS
Hims & Hers Health
2,442227.94 million201.13 millionOptionable
Medpace Holdings, Inc. stock logo
MEDP
Medpace
6,20028.56 million22.71 millionOptionable
ResMed Inc. stock logo
RMD
ResMed
10,600145.68 million144.73 millionOptionable

Recent News About These Companies

ResMed (NYSE:RMD) CEO Michael Farrell Sells 4,991 Shares
Piper Sandler Remains a Hold on Resmed (RMD)
ResMed Inc. $RMD Shares Sold by Strs Ohio

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Encompass Health stock logo

Encompass Health NYSE:EHC

$106.64 +0.00 (+0.00%)
Closing price 05/15/2026 03:59 PM Eastern
Extended Trading
$106.74 +0.10 (+0.10%)
As of 06:34 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions. It offers services through the Medicare program to federal government, managed care plans and private insurers, state governments, and other patients. The company was formerly known as HealthSouth Corporation and changed its name to Encompass Health Corporation in January 2018. The company was incorporated in 1984 and is based in Birmingham, Alabama.

Hims & Hers Health stock logo

Hims & Hers Health NYSE:HIMS

$25.06 +0.01 (+0.06%)
Closing price 05/15/2026 03:59 PM Eastern
Extended Trading
$23.51 -1.56 (-6.20%)
As of 07:21 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.

Medpace stock logo

Medpace NASDAQ:MEDP

$415.27 0.00 (0.00%)
Closing price 05/15/2026 04:00 PM Eastern
Extended Trading
$416.12 +0.85 (+0.20%)
As of 04:27 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Medpace Holdings, Inc. engages in the provision of outsourced clinical development services to the biotechnology, pharmaceutical and medical device industries. Its services include medical department, clinical trial management, data-driven feasibility, study-start-up, clinical monitoring, regulatory affairs, patient recruitment and retention, medical writing, biometrics and data sciences, pharmacovigilance, core laboratory, laboratories, clinics, and quality assurance. The company was founded by August James Troendle in 1992 and is headquartered in Cincinnati, OH.

ResMed stock logo

ResMed NYSE:RMD

$202.03 +0.15 (+0.08%)
Closing price 05/15/2026 03:59 PM Eastern
Extended Trading
$203.31 +1.28 (+0.63%)
As of 07:10 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications for the healthcare markets. The company operates in two segments, Sleep and Respiratory Care, and Software as a Service. It offers various products and solutions for a range of respiratory disorders, including ApneaLink Air, a portable diagnostic device that measures oximetry, respiratory effort, pulse, nasal flow, and snoring; and NightOwl, a portable, cloud-connected, and disposable diagnostic device that measures AHI based on derived peripheral arterial tone, actigraphy, and oximetry over several nights. The company also provides AirView, a cloud-based system that enables remote monitoring and changing of patients' device settings; myAir, a personalized therapy management application for patients with sleep apnea that provides support, education, and troubleshooting tools for increased patient engagement and improved compliance; U-Sleep, a compliance monitoring solution that enables home medical equipment (HME) to streamline their sleep programs; connectivity module and propeller solutions; and Propeller portal. It offers out-of-hospital software solution, such as Brightree business management software and service solutions to providers of HME, pharmacy, home infusion, orthotics, and prosthetics services; MatrixCare care management and related ancillary solutions to senior living, skilled nursing, life plan communities, home health, home care, and hospice organizations, as well as related accountable care organizations; HEALTHCAREfirst that offers electronic health record, software, billing and coding services, and analytics for home health and hospice agencies; and MEDIFOX DAN's software solutions. The company markets its products to sleep clinics, home healthcare dealers, and hospitals through a network of distributors and direct sales force. ResMed Inc. was founded in 1989 and is headquartered in San Diego, California.